NCT05291156 2024-02-01CAVE-2 GOIM Study: a Clinical Study of the Combination of Avelumab Plus Cetuximab as Rechallenge StrategyUniversity of Campania Luigi VanvitelliPhase 2 Unknown173 enrolled
NCT03150706 2020-04-03Avelumab for MSI-H or POLE Mutated Metastatic Colorectal CancerAsan Medical CenterPhase 2 Unknown33 enrolled